OÜ PharmaNineRegistered
Key figures
5 007 328 €+5,9%
Revenue 2025
+14,3%
Average annual growth 2020–2025
Ratios
20250,1%
Profit margin
2,1%
EBITDA margin
3,9%
Equity ratio
0,7×
Current ratio
7,0%
Return on equity
1137 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 1 257 585 € | 18 | 29 316 € |
| Q1 2026 | 1 402 438 € | 16 | 29 168 € |
| Q4 2025 | 1 271 962 € | 16 | 27 787 € |
| Q3 2025 | 1 182 920 € | 19 | 26 667 € |
| Q2 2025 | 1 230 696 € | 17 | 27 494 € |
| Q1 2025 | 1 267 392 € | 15 | 30 872 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Summary of financial statements2020–2025
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||
| Total current assets | 569 806 | 630 023 | 915 531 | 820 093 | 757 120 | 800 782 |
| Total non-current assets | 1 218 058 | 1 086 059 | 953 694 | 626 232 | 526 035 | 425 838 |
| Total assets | 1 787 864 | 1 716 082 | 1 869 225 | 1 446 325 | 1 283 155 | 1 226 620 |
| Balance sheet — liabilities and equity | ||||||
| Current liabilities | 1 948 441 | 1 723 267 | 1 883 805 | 1 413 449 | 1 238 345 | 1 178 422 |
| Non-current liabilities | — | — | — | — | — | — |
| Total liabilities | 1 948 441 | 1 723 267 | 1 883 805 | 1 413 449 | 1 238 345 | 1 178 422 |
| Share capital | 2500 | 2500 | 2500 | 2500 | 2500 | 2500 |
| Retained earnings of previous periods | — | −163 077 | −9685 | −17 080 | 30 376 | 42 310 |
| Profit for the year | −163 077 | 153 392 | −7395 | 47 456 | 11 934 | 3388 |
| Total equity | −160 577 | −7185 | −14 580 | 32 876 | 44 810 | 48 198 |
| Income statement | ||||||
| Sales revenue | 2 570 723 | 3 788 055 | 4 124 646 | 4 432 525 | 4 730 051 | 5 007 328 |
| Operating profit | −163 079 | 153 390 | −7400 | 47 441 | 11 926 | 3384 |
| EBITDA | −64 433 | 285 738 | 124 965 | 142 569 | 112 123 | 103 581 |
| Profit before income tax | −163 077 | 153 392 | −7395 | 47 456 | 11 934 | 3388 |
| Profit for the reporting year | −163 077 | 153 392 | −7395 | 47 456 | 11 934 | 3388 |
| Labour costs | 52 076 | 72 577 | 182 223 | 204 484 | 246 747 | 253 697 |
| Depreciation of non-current assets | 98 646 | 132 348 | 132 365 | 95 128 | 100 197 | 100 197 |
| Other indicators | ||||||
| Employees | 1 | 1 | 4 | 4 | 4 | 8 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Related companies
Same activity — Ravimite jaemüük